A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath ...

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath ...

A significant proportion of patients developed exocrine pancreatic insufficiency 12 months after a diagnosis of acute ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD). Design ...

Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe ...

While the benefits of this tradition were long understudied, modern-day research has revealed that the antioxidants in rice inhibit elastase, an enzyme that breaks down elastin in skin.

Financial writer rates Mereo BioPharma stock as Hold despite recent positive data, citing uncertainties around Phase 3 ...

By inhibiting DPP1, brensocatib prevents the activation of key proteases, including neutrophil elastase, which are known to degrade lung tissue and exacerbate inflammation. The ASPEN study appears ...

The Peak Bio pipeline includes an antibody-drug-conjugate (ADC) platform that includes novel toxins and linkers coupled with important cancer antibody targets and a Phase 2-ready neutrophil elastase ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases ...